Skip to main content
Medic Debate
- The Antidote to Medical Misinformation and Propaganda!
Languages
Dansk
Nederlands
English
Français
Deutsch
Italiano
Español
Kiswahili
Svenska
Search form
Search
Main menu
Home
Search
About us
Books
Category Search
Log In
Recent posts
Treatment Protocols
You are here
Home
Naltrexone
Items per page
5
10
20
40
60
100
Title
Average Rating
Reversal of Signs and Symptoms of a B-Cell Lymphoma in a Patient Using Only Low-Dose Naltrexone
100.00%
63 year old woman with stage III malignant melanoma
100.00%
Low Dose naltrexone
100.00%
75 year old man, Prostate Cancer with bone and liver metastasis
100.00%
Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
100.00%
Fibromyalgia Symptoms Are Reduced by Low-Dose Naltrexone: A Pilot Study.
95.00%
Low-dose naltrexone for disease prevention and quality of life.
95.00%
The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alp
90.00%
Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic ca
90.00%
Immunomodulatory effects of opioids.
90.00%
71 year old woman, Pancraetic cancer with liver and lung metastasis.
90.00%
Low dose naltrexone for induction of remission in Crohn's disease.
90.00%
Low-dose naltrexone therapy improves active Crohn's disease.
90.00%
Low-dose naltrexone for the treatment of irritable bowel syndrome: a pilot study.
90.00%
The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial.
90.00%
Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multipl
80.00%
Low-Dose Naltrexone Therapy Improves Active Crohn’s Disease
80.00%
Oxytrex minimizes physical dependence while providing effective analgesia: a randomized controlled trial in low back pain.
80.00%
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain
80.00%
Reduced cannabis use after low-dose naltrexone addition to opioid detoxification.
70.00%
Early outcomes following low dose naltrexone enhancement of opioid detoxification.
60.00%
Tolerance to the anticonvulsant effect of morphine in mice: blockage by ultra-low dose naltrexone.
60.00%
Anxiety- and depressive-like responses and c-fos activity in preproenkephalin knockout mice: oversensitivity hypothesis of enkephalin deficit-induced posttraumatic stress disorder.
60.00%